Cellectar Biosciences Inc (NASDAQ:CLRB) has a beta value of 0.99 and has seen 1.46 million shares traded in the recent trading session. The company, currently valued at $102.89M, closed the recent trade at $2.87 per share which meant it gained $0.35 on the day or 13.89% during that session. The CLRB stock price is -55.05% off its 52-week high price of $4.45 and 45.64% above the 52-week low of $1.56. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.25 million shares traded. The 3-month trading volume is 514.30K shares.
The consensus among analysts is that Cellectar Biosciences Inc (CLRB) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cellectar Biosciences Inc (NASDAQ:CLRB) trade information
Sporting 13.89% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the CLRB stock price touched $2.87 or saw a rise of 2.05%. Year-to-date, Cellectar Biosciences Inc shares have moved 3.61%, while the 5-day performance has seen it change 12.11%. Over the past 30 days, the shares of Cellectar Biosciences Inc (NASDAQ:CLRB) have changed 2.50%. Short interest in the company has seen 2.27 million shares shorted with days to cover at 4.33.
Wall Street analysts have a consensus price target for the stock at $12, which means that the shares’ value could jump 76.08% from the levels at last check today. The projected low price target is $12 while the price target rests at a high of $12. In that case, then, we find that the latest price level in today’s session is -318.12% off the targeted high while a plunge would see the stock gain -318.12% from the levels at last check today.
Cellectar Biosciences Inc (CLRB) estimates and forecasts
Figures show that Cellectar Biosciences Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -17.53% over the past 6 months, with this year growth rate of 40.95%, compared to 11.70% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 43.13% over the past 5 years.
CLRB Dividends
Cellectar Biosciences Inc is expected to release its next earnings report in August this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
